A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-5D-derived utility values

References

• ParisiRSymmonsDPMGriffithsCEMAshcroftDMGlobal epidemiology of psoriasis: a systematic review of incidence and prevalenceJ Invest Dermatol2012133237738523014338
   PubMed Web of Science ®Google Scholar
• YeungHTakeshitaJMehtaNNPsoriasis severity and the prevalence of major medical comorbidity: a population-based studyJAMA Dermatol2013149101173117923925466
   PubMed Web of Science ®Google Scholar
• The Lewin Group, IncThe Burden of Skin Diseases 2005Cleveland, OHThe Society for Investigative Dermatology2005 Available from: http://www.lewin.com/~/media/Lewin/Site_Sections/Publications/april2005skindisease.pdfAccessed April 16, 2014
   Google Scholar
• GriffithsCEBarkerJNPathogenesis and clinical features of psoriasisLancet2007370958326327117658397
   PubMed Web of Science ®Google Scholar
• TanXFeldmanSRBalkrishnanRQuality of life issues and measurement in patients with psoriasisPsoriasis: Targets and Therapy2012201221323
   Google Scholar
• MillerIMEllervikCYazdanyarSJemecGBMeta-analysis of psoriasis, cardiovascular disease, and associated risk factorsJ Am Acad Dermatol20136961014102424238156
   PubMed Web of Science ®Google Scholar
• HrehorówESalomonJMatusiakLReichASzepietowskiJCPatients with psoriasis feel stigmatizedActa Derm Venereol2012921677221879243
   PubMed Web of Science ®Google Scholar
• AnsteyAMcAteerHKamathNPercivalFExtending psychosocial assessment of patients with psoriasis in the UK, using a self-rateds, web-based surveyClin Exp Dermatol201237773574022998542
   PubMed Web of Science ®Google Scholar
• EversAWLuYDullerPvan der ValkPGKraaimaatFWvan de KerkhofPCCommon burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitisBr J Dermatol200515261275128115948993
   PubMed Web of Science ®Google Scholar
• BhosleMJKulkarniAFeldmanSRBalkrishnanRQuality of life in patients with psoriasisHealth Qual Life Outcomes20064353716756666
   PubMed Web of Science ®Google Scholar
• JemecGBWulfHCPatient-physician consensus on quality of life in dermatologyClin Exp Dermatol19962131771798914355
   PubMed Web of Science ®Google Scholar
• RappSRFeldmanSRExumMLFleischerABReboussinDMPsoriasis causes as much disability as other major medical diseasesJ Am Acad Dermatol1999413 Pt 140140710459113
   PubMed Web of Science ®Google Scholar
• BrooksREuroQol: the current state of playHealth Policy1996371537210158943
   PubMed Web of Science ®Google Scholar
• MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementJ Clin Epidemiol200962101006101219631508
   PubMed Web of Science ®Google Scholar
• ChristophersEBarkerJNGriffithsCEThe risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinicsJ Eur Acad Dermatol Venereol201024554855419874432
   PubMed Web of Science ®Google Scholar
• DaudénEGriffithsCEOrtonneJPImprovements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL studyJ Eur Acad Dermatol Venereol200923121374138219563497
   PubMed Web of Science ®Google Scholar
• KalbREBlauveltASofenHLEffect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trialJ Drugs Dermatol201312887488023986160
   PubMed Web of Science ®Google Scholar
• KulkarniASBalkrishnanRRichmondDPearceDJFeldmanSRMedication-related factors affecting health care outcomes and costs for patients with psoriasis in the United StatesJ Am Acad Dermatol2005521273115627077
   PubMed Web of Science ®Google Scholar
• NorlinJMSteen CarlssonKPerssonUSchmitt-EgenolfMSwitch to biological agent in psoriasis significantly improved clinical and patient-reported outcomes in real-world practiceDermatology2012225432633223328678
   PubMed Web of Science ®Google Scholar
• NorlinJMSteen CarlssonKPerssonUSchmitt-EgenolfMAnalysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patientsBr J Dermatol2012166479780222182212
   PubMed Web of Science ®Google Scholar
• RosenCFMussaniFChandranVEderLThavaneswaranAGladmanDDPatients with psoriatic arthritis have worse quality of life than those with psoriasis aloneRheumatology (Oxford)201251357157622157469
   PubMed Web of Science ®Google Scholar
• ShikiarRWillianMKOkunMMThompsonCSRevickiDAThe validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II studyHealth Qual Life Outcomes200647117005043
   PubMed Web of Science ®Google Scholar
• ShikiarRHeffernanMLangleyRGWillianMKOkunMMRevickiDAAdalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trialJ Dermatolog Treat2007181253117365264
   PubMed Web of Science ®Google Scholar
• WadeAGCrawfordGMPumfordNKoscielnyVMaycockSMcConnachieABaseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluationBMC Med Res Methodol2011119121672203
   PubMed Web of Science ®Google Scholar
• WeissSCKimballABLiewehrDJBlauveltATurnerMLEmanuelEJQuantifying the harmful effect of psoriasis on health-related quality of lifeJ Am Acad Dermatol200247451251812271293
   PubMed Web of Science ®Google Scholar
• WeissSCRehmusWKimballABAn assessment of the cost-utility of therapy for psoriasisTher Clin Risk Manag20062332532818360608
   PubMedGoogle Scholar
• DyerMTGoldsmithKASharplesLSBuxtonMJA review of health utilities using the EQ-5D in studies of cardiovascular diseaseHealth Qual Life Outcomes201081320109189
   PubMed Web of Science ®Google Scholar
• JanssenMFLubetkinEISekhoboJPPickardASThe use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitusDiabet Med201128439541321392061
   PubMed Web of Science ®Google Scholar
• LiemYSBoschJLHuninkMGPreference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysisValue Health200811473374118194399
   PubMed Web of Science ®Google Scholar
• McLernonDJDillonJDonnanPTHealth-state utilities in liver disease: a systematic reviewMed Decis Making200828458259218424560
   PubMed Web of Science ®Google Scholar
• PickardASWilkeCTLinHWLloydAHealth utilities using the EQ-5D in studies of cancerPharmacoeconomics200725536538417488136
   PubMed Web of Science ®Google Scholar
• ToshJBrazierJEvansPLongworthLA review of generic preference-based measures of health-related quality of life in visual disordersValue Health201215111812722264979
   PubMed Web of Science ®Google Scholar
• National Institute of Mental Health [webpage on the Internet]What is depression?Bethesda, MDNational Institute of Mental Health2011 Available from: http://www.nimh.nih.gov/health/publications/depression/index.shtml#pub4Accessed May 13, 2014
   Google Scholar
• ReichKSegaertSVan de KerkhofPOnce-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasisDermatology2009219323924919752505
   PubMed Web of Science ®Google Scholar
• SwinburnPLloydABoyeKSEdson-HerediaEBowmanLJanssenBDevelopment of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UKValue Health20131681156116224326169
   PubMed Web of Science ®Google Scholar